Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label previous answer version answering member constituency answering member printed answering member label
tabling member	label

Search

1143540

	registered interest
	date	02/09/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Infant Foods
	house id	1
	legislature	25259 pref label House of Commons
	question text	To as the Secretary of State for Health and Social Care, pursuant to the Answer of 14 May 2019 to Question 247997 on Infant Foods, if he will publish the (a) content discussed and (b) decisions made in the meetings his Department has had with representatives of the formula milk industry in (i) 2018 and (ii) 2019.
	tabling member constituency	Washington and Sunderland West
	tabling member printed	Mrs Sharon Hodgson
	uin	284948
	answer	answer is ministerial correction date of answer 09/09/2019 answer text <p>The content discussed at the meetings is set out in the following table. No decisions were taken at any of these meetings.</p><p> </p><table><tbody><tr><td><p>Date</p></td><td><p>Organisation</p></td><td><p>Content discussed</p></td></tr><tr><td><p>26 February 2018</p></td><td><p>Nestle</p></td><td><p>Presentation on action on sustainable diets</p></td></tr><tr><td><p>28 March 2018</p></td><td><p>Singapore Government and trade delegation</p></td><td><p>General discussion on Infant formula</p></td></tr><tr><td><p>25 April 2018</p></td><td><p>Danone and Nutrica</p></td><td><p>Early Years Nutrition Partnership</p></td></tr><tr><td><p>6 June 2018</p></td><td><p>British Specialist Nutrition Association (BSNA), Nestle, Nutrica</p></td><td><p>Notifications for Foods for Special Medical Purposes</p></td></tr><tr><td><p>22 June 2018</p></td><td><p>Nestle</p></td><td><p>Planning for visit</p></td></tr><tr><td><p>4 July 2018</p></td><td><p>Nestle</p></td><td><p>Visit</p></td></tr><tr><td><p>11 July 2018</p></td><td><p>Danone</p></td><td><p>Aptamil</p></td></tr><tr><td><p>30 July 2018</p></td><td><p>Danone</p></td><td><p>Childhood Obesity Chapter 2</p></td></tr><tr><td><p>14 August 2018</p></td><td><p>Nestle</p></td><td><p>Childhood Obesity Chapter 2</p></td></tr><tr><td><p>22 August 2018</p></td><td><p>BSNA</p></td><td><p>EU exit preparation</p></td></tr><tr><td><p>10 September 2018</p></td><td><p>Danone and Nestle</p></td><td><p>Advertising roundtable</p></td></tr><tr><td><p>14 November 2018</p></td><td><p>BSNA</p></td><td><p>Nutrition legislation meeting</p></td></tr><tr><td><p>15 November 2018</p></td><td><p>Danone</p></td><td><p>Reformulation, Brexit pressure, and Chapter 2</p></td></tr><tr><td><p>22 November 2018</p></td><td><p>BSNA</p></td><td><p>Forthcoming CODEX CCNFSDU40</p></td></tr></tbody></table> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 09/09/2019 15:45:03 answering member 4380 label Biography information for Jo Churchill
	tabling member	1521 label Biography information for Mrs Sharon Hodgson

1194992

	registered interest
	date	12/05/2020
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Radiotherapy
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care if he will make an assessment of the potential merits of implementing the recommendations contained in the Manifesto published by the All Party Parliamentary Group for Radiotherapy, published on 18 July 2019.
	tabling member constituency	Easington
	tabling member printed	Grahame Morris
	uin	46037
	answer	answer is ministerial correction date of answer 20/05/2020 answer text <p>The NHS Long Term Plan set out the priorities for radiotherapy services in the National Health Service in England.</p><p>This included £130 million being spent on upgrading radiotherapy machines, which has now been completed.</p><p>In April 2012, the Government announced that £250 million will be invested to build proton beam therapy (PBT) facilities at The Christie Hospital in Manchester and University College London Hospital in London. This commitment was reaffirmed in the NHS Long Term Plan, and The Christie PBT centre became operational in August 2018.</p><p>Reforms to the specialised commissioning payments for radiotherapy hypofractionation will be introduced to support further equipment upgrades. This is in progress and, in the interim, specialised commissioners have recurrently allocated £12 million to support the expansion of stereotactic ablative radiotherapy provision.</p><p> </p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 20/05/2020 13:50:37 answering member 4380 label Biography information for Jo Churchill previous answer version 22347 answering member constituency Bury St Edmunds answering member printed Jo Churchill answering member 4380 label Biography information for Jo Churchill
	tabling member	3973 label Biography information for Grahame Morris

1175052

	registered interest
	date	31/01/2020
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	HIV Infection: Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care what discussions he has had with local health commissioners on ensuring access for gay and bisexual men in Kingston upon Hull West and Hessle constituency to the PrEP Impact Trial.
	tabling member constituency	Kingston upon Hull West and Hessle
	tabling member printed	Emma Hardy
	uin	10781
	answer	answer is ministerial correction date of answer 10/02/2020 answer text <p>Pre-exposure prophylaxis (PrEP) is currently provided in England through the three-year PrEP Impact Trial. Participation in the trial is on a voluntary basis and it is for clinics and local authorities to decide the number of allocated places they can accept. The Department has held no discussions with local health commissioners in relation to the pause in recruitment for gay and bisexual men on the PrEP impact trial at Conifer-Wilberforce Health Centre or access to the trial in Kingston upon Hull West and Hessle constituency.</p><p> </p><p><strong> </strong></p><p><strong> </strong></p> answering member constituency Bury St Edmunds answering member printed Jo Churchill grouped question UIN 10780 question first answered 10/02/2020 15:37:54 answering member 4380 label Biography information for Jo Churchill
	tabling member	4645 label Biography information for Emma Hardy

1234553

	registered interest
	date	15/09/2020
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Asthma: Medical Equipment
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care what estimate he has made of the size of the stockpiles of inhalers that are available for prescription or purchase in the UK as of 15 September 2020.
	tabling member constituency	Islington South and Finsbury
	tabling member printed	Emily Thornberry
	uin	90075
	answer	answer is ministerial correction date of answer 23/09/2020 answer text <p>Our priority is to ensure that patients continue to have access to medicines and medical products they need. We are working closely with industry, the National Health Service and others in the supply chain to ensure that precautions are in place to reduce the likelihood of future shortages</p><p>The Government continues to hold stockpiles of medicines, including many of those medicines raised in the Rt. hon. Member’s questions, to cope with a range of scenarios, and robust contingency planning continues to ensure that the country is prepared for a possible second peak of COVID-19 infections and the end of the Transition period.</p><p>The Essential Medicines Buffer Stock (EMBS) supports the NHS in the event of a pandemic or other health emergency by ensuring the continued availability of medicines that are in routine use within the NHS in the event that the supply chain is interrupted. Volumes of the medicines listed in the EBMS for the requested dates are shown in the following table. The original EMBS contracts ended in October 2019 and the current ones expire on 31 March 2021.</p><table><tbody><tr><td><p>Volumes in EMBS (packs/singles)</p></td><td><p>Prior to 31 October 2019</p></td><td><p>On 15 September 2020</p></td></tr><tr><td><p>paracetamol_500mg_Caps/Tabs 100 pack</p></td><td><p>706,072</p></td><td><p>2,965,503</p></td></tr><tr><td><p>paracetamol_500mg_Caps/Tabs 100 pack</p></td><td><p>4,942,506</p></td><td><p> </p></td></tr><tr><td><p>paracetamol_500mg-Caps/Tabs 100 pack</p></td><td><p>706,072</p></td><td><p> </p></td></tr><tr><td><p>paracetamol_125mg suppository 10 pack</p></td><td><p>3,578</p></td><td><p> </p></td></tr><tr><td><p>paracetamol_120mg/5ml liquid 100ml single</p></td><td><p>340,062</p></td><td><p> </p></td></tr><tr><td><p>paracetamol_250mg/5ml_liquid 100ml single</p></td><td><p>201,159</p></td><td><p> </p></td></tr><tr><td><p>paracetamol_500mg_Caps/Tabs 100 pack</p></td><td><p>706,072</p></td><td><p> </p></td></tr><tr><td><p>salbutamol_2mg/ml 2.5ml_nebules 20 pack</p></td><td><p>246,246</p></td><td><p> </p></td></tr><tr><td><p>Salbutamol_100mcg x 200 dose_MDI single inhalers</p></td><td><p>3,956,254</p></td><td><p>2,600,000</p></td></tr><tr><td><p>ibuprofen_100mg/5ml_liquid 100ml-150ml-500ml (volume in 100ml) singles</p></td><td><p>230,400</p></td><td><p> </p></td></tr><tr><td><p>ibuprofren_400mg_Caps/Tabs 84 pack</p></td><td><p>591,883</p></td><td><p> </p></td></tr><tr><td><p>amoxicillin_125mg/5ml_liquid 100ml singles</p></td><td><p>234,925</p></td><td><p> </p></td></tr><tr><td><p>amoxicillin_125mg/5ml_liquid 100ml singles</p></td><td><p>234,925</p></td><td><p> </p></td></tr><tr><td><p>amoxicillin_250mg_Caps/Tabs 21 pack</p></td><td><p>235,874</p></td><td><p> </p></td></tr><tr><td><p>amoxicillin_500mg_Caps/Tabs 21 pack</p></td><td><p>1,714,429</p></td><td><p> </p></td></tr><tr><td><p>amoxicillin_125mg/5ml_liquid 100ml singles</p></td><td><p>313,234</p></td><td><p> </p></td></tr><tr><td><p>Amoxicillin_250mg_Caps/Tabs 21 pack</p></td><td><p>157,249</p></td><td><p> </p></td></tr><tr><td><p>Amoxicillin_500mg_Caps/Tabs 21 pack</p></td><td><p>489,837</p></td><td><p> </p></td></tr></tbody></table><p> </p><p>In preparation for a potential imminent second wave of COVID-19 and to protect the security of the supply of critical life-saving medicines and patient health across the United Kingdom, a clinically-led assessment of medicines that should be stockpiled was undertaken in May and June 2020 and this was fed into a tender exercise that ran from 24 July to 10 August 2020.</p><p>Paracetamol and insulin are amongst the medicines that were identified and tendered for as part of this exercise and we will shortly be awarding contracts to secure supplies of these medicines for the autumn and winter. Details of the tender exercise can be found at the following links:</p><p><a href="https://ted.europa.eu/udl?uri=TED:NOTICE:355937-2020:HTML:EN:HTML&amp;tabId=1&amp;tabLang=en#id4-VI" target="_blank">https://ted.europa.eu/udl?uri=TED:NOTICE:355937-2020:HTML:EN:HTML&amp;tabId=1&amp;tabLang=en#id4-VI</a></p><p><a href="https://www.contractsfinder.service.gov.uk/Notice/b8bf439c-76d1-4fa6-952d-6b65bd659021" target="_blank">https://www.contractsfinder.service.gov.uk/Notice/b8bf439c-76d1-4fa6-952d-6b65bd659021</a></p><p>With regard to stocks of medicines on UK soil owned and held by suppliers themselves, commercially sensitive information has been shared confidentially with the Department by suppliers of medicines to the UK, to support various contingency programmes. For this reason, we cannot share information received from suppliers, including on their UK stock levels, with third parties.</p> answering member constituency Bury St Edmunds answering member printed Jo Churchill grouped question UIN 90068 90069 90070 90071 90072 90073 90074 90076 90077 90078 90079 90080 90081 90083 question first answered 23/09/2020 12:14:21 answering member 4380 label Biography information for Jo Churchill
	tabling member	1536 label Biography information for Emily Thornberry

1191188

	registered interest
	date	28/04/2020
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Hygiene and Protective Clothing: Manufacturing Industries
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care what plans he has to support small and medium sized businesses to manufacture (a) personal protective equipment and (b) hand sanitiser.
	tabling member constituency	Midlothian
	tabling member printed	Owen Thompson
	uin	41119
	answer	answer is ministerial correction date of answer 03/08/2020 answer text <p>There isn't a historic minimum annual amount requirement to be part of the supply chain. The minimum requirements are for volume offered now, not volumes provided historically. Businesses must meet certain minimum financial criteria, must be able to demonstrate that it can supply Personal Protective Equipment (PPE) at volume, and must pass various other checks and controls.</p><p>Manufacture of PPE must meet product safety legislation outlined in the guidance and appropriate health and safety technical specifications.</p><p>Lord Deighton is leading the Government effort by British industry to manufacture PPE including hand sanitiser. The Government has contracted with over 175 new suppliers able to deliver at the scale and pace the UK requires. The combined DIT, FCO and DHSC efforts have resulted in DHSC raising purchase orders for over 27.8 billion items of PPE; direct from new relationships in source countries, as well as through our trusted UK suppliers to the NHS, who themselves are using their global connections to help us. We have rapidly processed over 24,000 cases from over 15,000 suppliers to ensure they meet the safety and quality standards that our NHS staff need, as well as prioritising offers of larger volumes. We have so far actively engaged with over 99% of the companies that have offered PPE.</p><p><strong> </strong></p> answering member constituency Bury St Edmunds answering member printed Jo Churchill grouped question UIN 41120 41121 question first answered 03/08/2020 10:23:39 answering member 4380 label Biography information for Jo Churchill
	tabling member	4482 label Biography information for Owen Thompson

1173314

	registered interest
	date	27/01/2020
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Pharmacy
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care what steps he is taking to improve services provided by community pharmacists.
	tabling member constituency	Southend West
	tabling member printed	Sir David Amess
	uin	900450
	answer	answer is ministerial correction date of answer 28/01/2020 answer text <p>Through our ‘pharmacy first’ approach, we want to unlock the potential of community pharmacy.</p><p>Our landmark five-year contractual framework sets out an expanded role for community pharmacy to help people stay well closer to home.</p><p>This winter, more than 114,000 people with minor illnesses or medication needs have received same-day consultations with their highly skilled local community pharmacist following a new referral service from NHS 111.</p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 28/01/2020 16:09:41 answering member 4380 label Biography information for Jo Churchill
	tabling member	44 label Biography information for Sir David Amess

1234555

	registered interest
	date	15/09/2020
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Asthma: Medical Equipment
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care when the Government last made an assessment of the level of stockpiling of inhalers required in preparation for (a) a second wave of covid-19 and (b) the end of the transition period and if he will publish that assessment.
	tabling member constituency	Islington South and Finsbury
	tabling member printed	Emily Thornberry
	uin	90076
	answer	answer is ministerial correction date of answer 23/09/2020 answer text <p>Our priority is to ensure that patients continue to have access to medicines and medical products they need. We are working closely with industry, the National Health Service and others in the supply chain to ensure that precautions are in place to reduce the likelihood of future shortages</p><p>The Government continues to hold stockpiles of medicines, including many of those medicines raised in the Rt. hon. Member’s questions, to cope with a range of scenarios, and robust contingency planning continues to ensure that the country is prepared for a possible second peak of COVID-19 infections and the end of the Transition period.</p><p>The Essential Medicines Buffer Stock (EMBS) supports the NHS in the event of a pandemic or other health emergency by ensuring the continued availability of medicines that are in routine use within the NHS in the event that the supply chain is interrupted. Volumes of the medicines listed in the EBMS for the requested dates are shown in the following table. The original EMBS contracts ended in October 2019 and the current ones expire on 31 March 2021.</p><table><tbody><tr><td><p>Volumes in EMBS (packs/singles)</p></td><td><p>Prior to 31 October 2019</p></td><td><p>On 15 September 2020</p></td></tr><tr><td><p>paracetamol_500mg_Caps/Tabs 100 pack</p></td><td><p>706,072</p></td><td><p>2,965,503</p></td></tr><tr><td><p>paracetamol_500mg_Caps/Tabs 100 pack</p></td><td><p>4,942,506</p></td><td><p> </p></td></tr><tr><td><p>paracetamol_500mg-Caps/Tabs 100 pack</p></td><td><p>706,072</p></td><td><p> </p></td></tr><tr><td><p>paracetamol_125mg suppository 10 pack</p></td><td><p>3,578</p></td><td><p> </p></td></tr><tr><td><p>paracetamol_120mg/5ml liquid 100ml single</p></td><td><p>340,062</p></td><td><p> </p></td></tr><tr><td><p>paracetamol_250mg/5ml_liquid 100ml single</p></td><td><p>201,159</p></td><td><p> </p></td></tr><tr><td><p>paracetamol_500mg_Caps/Tabs 100 pack</p></td><td><p>706,072</p></td><td><p> </p></td></tr><tr><td><p>salbutamol_2mg/ml 2.5ml_nebules 20 pack</p></td><td><p>246,246</p></td><td><p> </p></td></tr><tr><td><p>Salbutamol_100mcg x 200 dose_MDI single inhalers</p></td><td><p>3,956,254</p></td><td><p>2,600,000</p></td></tr><tr><td><p>ibuprofen_100mg/5ml_liquid 100ml-150ml-500ml (volume in 100ml) singles</p></td><td><p>230,400</p></td><td><p> </p></td></tr><tr><td><p>ibuprofren_400mg_Caps/Tabs 84 pack</p></td><td><p>591,883</p></td><td><p> </p></td></tr><tr><td><p>amoxicillin_125mg/5ml_liquid 100ml singles</p></td><td><p>234,925</p></td><td><p> </p></td></tr><tr><td><p>amoxicillin_125mg/5ml_liquid 100ml singles</p></td><td><p>234,925</p></td><td><p> </p></td></tr><tr><td><p>amoxicillin_250mg_Caps/Tabs 21 pack</p></td><td><p>235,874</p></td><td><p> </p></td></tr><tr><td><p>amoxicillin_500mg_Caps/Tabs 21 pack</p></td><td><p>1,714,429</p></td><td><p> </p></td></tr><tr><td><p>amoxicillin_125mg/5ml_liquid 100ml singles</p></td><td><p>313,234</p></td><td><p> </p></td></tr><tr><td><p>Amoxicillin_250mg_Caps/Tabs 21 pack</p></td><td><p>157,249</p></td><td><p> </p></td></tr><tr><td><p>Amoxicillin_500mg_Caps/Tabs 21 pack</p></td><td><p>489,837</p></td><td><p> </p></td></tr></tbody></table><p> </p><p>In preparation for a potential imminent second wave of COVID-19 and to protect the security of the supply of critical life-saving medicines and patient health across the United Kingdom, a clinically-led assessment of medicines that should be stockpiled was undertaken in May and June 2020 and this was fed into a tender exercise that ran from 24 July to 10 August 2020.</p><p>Paracetamol and insulin are amongst the medicines that were identified and tendered for as part of this exercise and we will shortly be awarding contracts to secure supplies of these medicines for the autumn and winter. Details of the tender exercise can be found at the following links:</p><p><a href="https://ted.europa.eu/udl?uri=TED:NOTICE:355937-2020:HTML:EN:HTML&amp;tabId=1&amp;tabLang=en#id4-VI" target="_blank">https://ted.europa.eu/udl?uri=TED:NOTICE:355937-2020:HTML:EN:HTML&amp;tabId=1&amp;tabLang=en#id4-VI</a></p><p><a href="https://www.contractsfinder.service.gov.uk/Notice/b8bf439c-76d1-4fa6-952d-6b65bd659021" target="_blank">https://www.contractsfinder.service.gov.uk/Notice/b8bf439c-76d1-4fa6-952d-6b65bd659021</a></p><p>With regard to stocks of medicines on UK soil owned and held by suppliers themselves, commercially sensitive information has been shared confidentially with the Department by suppliers of medicines to the UK, to support various contingency programmes. For this reason, we cannot share information received from suppliers, including on their UK stock levels, with third parties.</p> answering member constituency Bury St Edmunds answering member printed Jo Churchill grouped question UIN 90068 90069 90070 90071 90072 90073 90074 90075 90077 90078 90079 90080 90081 90083 question first answered 23/09/2020 12:14:21 answering member 4380 label Biography information for Jo Churchill
	tabling member	1536 label Biography information for Emily Thornberry

1247463

	registered interest
	date	30/10/2020
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Protective Clothing: Costs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, (a) What is the combined cost of the 11 largest contracts for the supply of Personal Protective Coveralls, (b) what is the total number of Personal Protective Coveralls procured under each contract, and (c) what is the unit price per Personal Protective Coverall by each supplier of the largest 11 contracts; and if he will make a statement.
	tabling member constituency	Harrow West
	tabling member printed	Gareth Thomas
	uin	109145
	answer	answer is ministerial correction date of answer 01/12/2020 answer text <p>Three hundred and seventy contracts have been awarded by the Department for the supply of all types of personal protective equipment (PPE). The published Contract Award Notices contain details on the different types of PPE ordered against each contract, information which is not collated centrally prior to publication. Purchase orders have been raised against these contracts for over 29 million coveralls which are in the process of being delivered to the United Kingdom or have already arrived and are then quality checked at our UK warehouses before being distributed to the frontline.</p><p>Information on the unit price of PPE ordered under each contract is considered commercially confidential.</p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 01/12/2020 09:32:53 answering member 4380 label Biography information for Jo Churchill
	tabling member	177 label Biography information for Gareth Thomas

1198258

	registered interest
	date	01/06/2020
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	University College Hospital: Radiotherapy
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, for what reason the opening of the proton beam therapy service at University College Hospital London has been delayed.
	tabling member constituency	Easington
	tabling member printed	Grahame Morris
	uin	51865
	answer	answer is ministerial correction date of answer 18/06/2020 answer text <p>NHS England and University College London Hospital (UCLH) are currently working with contractors to open the Proton Beam Therapy (PBT) centre as soon as possible following the COVID-19 pandemic. It is anticipated that the first patient treatment will be in 2021.</p><p>Apart from the current impact of COVID-19, the PBT service at UCLH has been delayed historically due to the complexity of the build on a constrained inner London site and, more recently due to water ingress, as reported to the National PBT Programme Board, the Department and the Infrastructure and Projects Authority. These historic issues have been resolved.</p> answering member constituency Bury St Edmunds answering member printed Jo Churchill grouped question UIN 51864 51866 51867 question first answered 18/06/2020 16:14:46 answering member 4380 label Biography information for Jo Churchill previous answer version 25900 answering member constituency Bury St Edmunds answering member printed Jo Churchill answering member 4380 label Biography information for Jo Churchill
	tabling member	3973 label Biography information for Grahame Morris

1305251

	registered interest
	date	23/03/2021
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Dental Services
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how many dental practices are open to new (a) adult and (b) child NHS patients in (i) Bolton and (ii) England as at 23 March 2021.
	tabling member constituency	Bolton South East
	tabling member printed	Yasmin Qureshi
	uin	174074
	answer	answer is ministerial correction date of answer 30/03/2021 answer text <p>Over 6,000 National Health Service dental practices in England have been able to see patients face to face since 8 June 2020.</p><p>In Bolton there are currently 30 NHS dental practices, of which six are operating as urgent dental providers, receiving referrals for any patients who require urgent treatment as well as referrals for looked after children.</p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 30/03/2021 15:24:16 answering member 4380 label Biography information for Jo Churchill
	tabling member	3924 label Biography information for Yasmin Qureshi